C3c intrathecal synthesis evaluation in patients with multiple sclerosis

Bárbara Padilla-Docal1, Alberto J Dorta-Contreras, Hermes Fundora-Hernández

  • 1Laboratorio Central de Líquido Cefalorraquídeo, Facultad de Ciencias Médicas Dr. Miguel Enriquez, Instituto Superior de Ciencias Médicas de La Habana, CP 11000 Havana City, Cuba. barbara.padilla@infomed.sod.cu

Abstract

Insights

The complement system is activated in multiple sclerosis (MS), with intrathecal synthesis of C3c indicating its involvement in myelin destruction. This suggests the complement system plays a role in MS immunopathogenesis.

Area of Science:

  • Neuroimmunology
  • Central Nervous System Disorders

Background:

  • Multiple sclerosis (MS) is a chronic, progressive central nervous system disease characterized by inflammation and myelin loss (demyelination).
  • The precise mechanisms driving MS immunopathogenesis, particularly myelin destruction, require further elucidation.

Purpose of the Study:

  • To investigate the potential involvement of the complement system in the immunopathogenesis of MS.
  • To determine if complement system activation contributes to myelin destruction in MS patients.

Main Methods:

  • Collected sera and cerebrospinal fluid (CSF) samples from twelve MS patients at hospital admission.
  • Quantified levels of C3c and albumin in sera and CSF using radial immunodiffusion.

Main Results:

  • Demonstrated high levels (over 80%) of intrathecal C3c synthesis in most MS patients.
  • Observed degradation of C3c within the CSF, suggesting complement system activation and subsequent breakdown.

Conclusions:

  • Intrathecal synthesis and liberation of C3c into the CSF indicate complement system activation in MS.
  • The findings support the role of the complement system in the immunopathogenesis of MS, potentially contributing to demyelination.

Related Concept Videos